Pretreatment with Darbepoetin Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity
Open Access
- 1 January 2009
- journal article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 24 (3) , 238-246
Abstract
Choi DE, et al. Korean J Intern Med. 2009 Sep;24(3):238-246. http://dx.doi.org/10.3904/kjim.2009.24.3.238Keywords
This publication has 31 references indexed in Scilit:
- Cisplatin Nephrotoxicity: A ReviewThe American Journal of the Medical Sciences, 2007
- Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in ratsToxicology, 2005
- Role of early plasma membrane events in chemotherapy-induced cell deathDrug Resistance Updates, 2005
- Attenuation of Interstitial Inflammation and Fibrosis by Recombinant Human Erythropoietin in Chronic Cyclosporine NephropathyAmerican Journal of Nephrology, 2005
- Erythropoietin Protects the Kidney against the Injury and Dysfunction Caused by Ischemia-ReperfusionJournal of the American Society of Nephrology, 2004
- An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotectionCardiovascular Research, 2004
- Erythropoietin protects against ischaemic acute renal injuryNephrology Dialysis Transplantation, 2004
- Preconditioning with erythropoietin protects against subsequent ischemia‐reperfusion injury in rat kidneyThe FASEB Journal, 2003
- A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in ratsToxicology, 1989